|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010362,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0205179,
umls-concept:C0238198,
umls-concept:C0332157,
umls-concept:C0441889,
umls-concept:C0444506,
umls-concept:C0521362,
umls-concept:C0728940,
umls-concept:C0935989
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-3-19
|
|
pubmed:abstractText |
Imatinib plasma trough levels (C(min)) have been reported to correlate with treatment outcomes in patients with gastrointestinal stromal tumors (GISTs). We therefore have evaluated the correlation between imatinib C(min) and the clinical characteristics of patients with GIST.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1554-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20177019-Adult,
pubmed-meshheading:20177019-Aged,
pubmed-meshheading:20177019-Antineoplastic Agents,
pubmed-meshheading:20177019-Cross-Sectional Studies,
pubmed-meshheading:20177019-Female,
pubmed-meshheading:20177019-Gastrectomy,
pubmed-meshheading:20177019-Gastrointestinal Stromal Tumors,
pubmed-meshheading:20177019-Humans,
pubmed-meshheading:20177019-Male,
pubmed-meshheading:20177019-Middle Aged,
pubmed-meshheading:20177019-Piperazines,
pubmed-meshheading:20177019-Pyrimidines,
pubmed-meshheading:20177019-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib.
|
|
pubmed:affiliation |
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article
|
